Stephen Wilton
Director/Board Member chez BIOSYENT INC.
Fortune : 16 679 $ au 31/03/2024
Profil
Stephen Wilton is an Independent Director at BioSyent, Inc. since 2014.
Prior to this, he worked as an Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and as a Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
He completed his undergraduate degree at the University of Toronto and his MBA at The Schulich School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOSYENT INC.
0,02% | 27/03/2024 | 2 600 ( 0,02% ) | 16 679 $ | 31/03/2024 |
Postes actifs de Stephen Wilton
| Sociétés | Poste | Début |
|---|---|---|
| BIOSYENT INC. | Director/Board Member | 16/01/2014 |
Anciens postes connus de Stephen Wilton
| Sociétés | Poste | Fin |
|---|---|---|
| The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01/01/2012 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | General Counsel | - |
Formation de Stephen Wilton
| University of Toronto | Undergraduate Degree |
| The Schulich School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOSYENT INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
| The Canadian Association of Chain Drug Stores |
